Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.
| dc.contributor.author | Gogus, F | |
| dc.contributor.author | Hamuryudan, V | |
| dc.contributor.author | Ozyazgan, Y | |
| dc.contributor.author | Yurdakul, S | |
| dc.contributor.author | Yazici, H | |
| dc.contributor.author | Melikoglu, M | |
| dc.contributor.author | Fresko, I | |
| dc.contributor.author | Mat, C | |
| dc.date.accessioned | 2021-03-05T10:52:34Z | |
| dc.date.available | 2021-03-05T10:52:34Z | |
| dc.identifier.citation | Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., Hamuryudan V., Yazici H., "Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial.", 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Louisiana, Amerika Birleşik Devletleri, 24 - 29 Ekim 2002, cilt.46 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_a56257c1-910e-49d9-948f-cbcdc6785ea1 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/110608 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | İmmünoloji ve Romatoloji | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp | |
| dc.subject | ROMATOLOJİ | |
| dc.title | Etanercept is beneficial in controlling the mucocutaneous lesions of Behcet's syndrome (BS) at short term but does not suppress the pathergy reaction and the cutaneous response to intradermally injected monosodium urate (MSU) crystals: A double blind placebo controlled trial. | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 46 | |
| dc.contributor.firstauthorID | 128112 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]